Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Name: Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan
Published: 2015
License: Public Domain

Ascletis Pharmaceuticals Co., Ltd. · 2015

ClinicalTrials.gov · Datasets · License: Public Domain · 2015

Open Source ↗

chronic hepatitis c, ravidasvir, hcv gt1, svr12, danoprevir/r, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Related documents